Eli Lilly Receives FDA Approval for Crohn’s Disease Treatment
In This Article:
Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn’s disease, an inflammatory bowel disease that causes chronic abdominal pain.
Terms and Privacy Policy